Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (301-310 of 953) with videos related to

Pageof 96
Sort By:
International Psychogeriatrics|September 2, 2011
Identifying target groups for the prevention of depression among caregivers of dementia patientsKarlijn J Joling, Filip Smit, Harm W J van Marwijk, et al.
Neurobiology of Aging|April 17, 2013
Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activityHanneke de Waal, Cornelis J Stam, Willem de Haan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaintsArgonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Alzheimer'S Research & Therapy|April 27, 2024
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic reviewMarlies Oosthoek, Lisa Vermunt, Arno de Wilde, et al.
Neuroepidemiology|May 29, 2013
Validation of the Amsterdam IADL Questionnaire©, a new tool to measure instrumental activities of daily living in dementiaSietske A M Sikkes, Dirk L Knol, Yolande A L Pijnenburg, et al.
European Journal of Heart Failure|August 28, 2007
Brain magnetic resonance imaging abnormalities in patients with heart failureRaymond L C Vogels, Wiesje M van der Flier, Barbera van Harten, et al.
Journal of the American Geriatrics Society|August 31, 2007
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels, Joukje M Oosterman, Barbera van Harten, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's DiseaseMarie-Paule E van Engelen, Flora T Gossink, Lieke S de Vijlder, et al.
Journal of Geriatric Psychiatry and Neurology|November 12, 2013
Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living QuestionnaireSietske A M Sikkes, Yolande A L Pijnenburg, Dirk L Knol, et al.
Clinical Chemistry|October 17, 2009
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Pageof 96

Showing results (301-310 of 953) with videos related to

Sort By:
Pageof 96
International Psychogeriatrics|September 2, 2011
Identifying target groups for the prevention of depression among caregivers of dementia patientsKarlijn J Joling, Filip Smit, Harm W J van Marwijk, et al.
Neurobiology of Aging|April 17, 2013
Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activityHanneke de Waal, Cornelis J Stam, Willem de Haan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaintsArgonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Alzheimer'S Research & Therapy|April 27, 2024
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic reviewMarlies Oosthoek, Lisa Vermunt, Arno de Wilde, et al.
Neuroepidemiology|May 29, 2013
Validation of the Amsterdam IADL Questionnaire©, a new tool to measure instrumental activities of daily living in dementiaSietske A M Sikkes, Dirk L Knol, Yolande A L Pijnenburg, et al.
European Journal of Heart Failure|August 28, 2007
Brain magnetic resonance imaging abnormalities in patients with heart failureRaymond L C Vogels, Wiesje M van der Flier, Barbera van Harten, et al.
Journal of the American Geriatrics Society|August 31, 2007
Profile of cognitive impairment in chronic heart failureRaymond L C Vogels, Joukje M Oosterman, Barbera van Harten, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's DiseaseMarie-Paule E van Engelen, Flora T Gossink, Lieke S de Vijlder, et al.
Journal of Geriatric Psychiatry and Neurology|November 12, 2013
Assessment of instrumental activities of daily living in dementia: diagnostic value of the Amsterdam Instrumental Activities of Daily Living QuestionnaireSietske A M Sikkes, Yolande A L Pijnenburg, Dirk L Knol, et al.
Clinical Chemistry|October 17, 2009
Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer diseaseCees Mulder, Nicolaas A Verwey, Wiesje M van der Flier, et al.
Pageof 96